Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1246190.RAE2zi-H9f41DF4_3ZoN0OBjsHVClGaenQNM1Y7PR6QCg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1246190.RAE2zi-H9f41DF4_3ZoN0OBjsHVClGaenQNM1Y7PR6QCg130_assertion type Assertion NP1246190.RAE2zi-H9f41DF4_3ZoN0OBjsHVClGaenQNM1Y7PR6QCg130_head.
- NP1246190.RAE2zi-H9f41DF4_3ZoN0OBjsHVClGaenQNM1Y7PR6QCg130_assertion description "[Overexpression of GYS1, MIF, and MYC is associated with adverse outcome and poor response to azacitidine in myelodysplastic syndromes and acute myeloid leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1246190.RAE2zi-H9f41DF4_3ZoN0OBjsHVClGaenQNM1Y7PR6QCg130_provenance.
- NP1246190.RAE2zi-H9f41DF4_3ZoN0OBjsHVClGaenQNM1Y7PR6QCg130_assertion evidence source_evidence_literature NP1246190.RAE2zi-H9f41DF4_3ZoN0OBjsHVClGaenQNM1Y7PR6QCg130_provenance.
- NP1246190.RAE2zi-H9f41DF4_3ZoN0OBjsHVClGaenQNM1Y7PR6QCg130_assertion SIO_000772 25487600 NP1246190.RAE2zi-H9f41DF4_3ZoN0OBjsHVClGaenQNM1Y7PR6QCg130_provenance.
- NP1246190.RAE2zi-H9f41DF4_3ZoN0OBjsHVClGaenQNM1Y7PR6QCg130_assertion wasDerivedFrom befree-2016 NP1246190.RAE2zi-H9f41DF4_3ZoN0OBjsHVClGaenQNM1Y7PR6QCg130_provenance.
- NP1246190.RAE2zi-H9f41DF4_3ZoN0OBjsHVClGaenQNM1Y7PR6QCg130_assertion wasGeneratedBy ECO_0000203 NP1246190.RAE2zi-H9f41DF4_3ZoN0OBjsHVClGaenQNM1Y7PR6QCg130_provenance.